No Data
No Data
Centre Testing International Group (300012.SZ): The business of Centre Testing International Group in the communications field covers testing of communications equipment, communication terminal certification, measurement and calibration, and other busines
Centre Testing International Group (300012.SZ) stated on its investor platform on July 22 that its business in the communications field covers communications, communications equipment testing, communications terminal certification, metrology and calibration services. The company has stable and long-term cooperation relationships with many domestic communication companies, and this business accounts for a small proportion of the company's revenue. Centre Testing International Group always adheres to the market demand-oriented, continues to pay attention to external market changes, and actively seizes potential market opportunities.
Centre Testing International Group (CTI) has been selected for S&P Global's "Sustainability Yearbook (China Edition) 2024".
On July 22, 2024, Shenzhen / PRNewswire / - On July 16, 2024, the "Grasping Opportunities, Driving Sustainable Development in the Future - S&P Global Sustainable1 Seminar and the Launching Ceremony of the "Sustainable Development Yearbook (China Edition) 2024 " event was held in Beijing to commend Chinese companies with outstanding performance in the field of sustainable development and to promote more companies to join the ranks of sustainable development. CTI Centre Testing International Group was invited to participate in this seminar and was successfully selected for S&P Global "Sustainable Development Yearbook (China Edition) 2024", marking the second year of participation for CTI Centre Testing International Group.
Could The Market Be Wrong About Centre Testing International Group Co. Ltd. (SZSE:300012) Given Its Attractive Financial Prospects?
Centre Testing International Group (300012.SZ): The testing business in the reproductive field accounts for a small proportion of the medical testing revenue.
On July 19th, GeLongHui reported that Centre Testing International Group (300012.SZ) stated on its investor interaction platform that the testing services of its medical business are quite extensive, covering over 3,800 testing items in areas such as pathology, biochemistry, immunity, microbiology, and bodily fluids, as well as genetic testing special projects, which can provide hospitals and patients with full-cycle diagnostic testing services for all types of diseases. In addition to launching diagnostic testing for precision treatment of cancer, its genetic special testing business has also launched detection projects such as tumor genetic risk assessment, tumor early screening, prognosis and recurrence monitoring for tumor treatment. In the past two years, the company's genetic testing...
Centre Testing International Group Forecasts Rise in Q2, H1 Profit
Centre Testing International Group: 2024 Interim Performance Forecast
No Data